DVA · Company KPIs
DaVita (DVA) KPIs
U.S. dialysis treatments, Outpatient dialysis centers, U.S. dialysis revenue per treatment, IKC patients in risk-based integrated care arrangements. As reported in SEC filings, with the source line for each figure.
U.S. dialysis treatments
7.33M for the period ended Sep 30, 2026
The filings read for this page do not define this measure.
| Period ended | Figure | Filing text |
|---|---|---|
| Sep 30, 2026 | 7.33M | Volume: Total U.S. dialysis treatments for the third quarter of 2026 were 7,329,644, or an average of 92,780 treatments per day, representing a per day increase of 0.1% compared to the second quarter of 2026.8-K filed 2026-10-29 |
| Jun 30, 2026 | 7.23M | Treatments · 7,226,600 · 7,029,525 · 14,256,1258-K filed 2026-08-04 |
| Mar 31, 2026 | 7.03M | Treatments · 7,029,525 · 7,264,520 · 7,040,5198-K filed 2026-05-05 |
| Dec 31, 2025 | 7.26M | Treatments · 7,264,520 · 7,242,725 · 28,733,9808-K filed 2026-02-02 |
| Sep 30, 2025 | 7.24M | Treatments · 7,242,725 · 7,186,217 · 21,469,4608-K filed 2025-10-29 |
| Jun 30, 2025 | 7.19M | Treatments · 7,242,725 · 7,186,217 · 21,469,4608-K filed 2025-10-29 |
| Mar 31, 2025 | 7.04M | Treatments · 7,029,525 · 7,264,520 · 7,040,5198-K filed 2026-05-05 |
Outpatient dialysis centers
3,269 at Sep 30, 2026
The filings read for this page do not define this measure.
| Period ended | Figure | Filing text |
|---|---|---|
| Sep 30, 2026 | 3,269 | As of September 30, 2026, we provided dialysis services to a total of approximately 298,100 patients at 3,269 outpatient dialysis centers, of which 2,671 centers were located in the United States and 598 centers were located in 14 countries outside of the United States.8-K filed 2026-10-29 |
| Jun 30, 2026 | 3,266 | As of June 30, 2026, we provided dialysis services to a total of approximately 298,500 patients at 3,266 outpatient dialysis centers, of which 2,671 centers were located in the United States and 595 centers were located in 14 countries outside of the United States.8-K filed 2026-08-04 |
| Mar 31, 2026 | 3,262 | As of March 31, 2026, we provided dialysis services to a total of approximately 296,300 patients at 3,262 outpatient dialysis centers, of which 2,666 centers were located in the United States and 596 centers were located in 14 countries outside of the United States.8-K filed 2026-05-05 |
| Dec 31, 2025 | 3,242 | As of December 31, 2025, we provided dialysis services to a total of approximately 295,000 patients at 3,242 outpatient dialysis centers, of which 2,657 centers were located in the United States and 585 centers were located in 14 countries outside of the United States.8-K filed 2026-02-02 |
| Sep 30, 2025 | 3,247 | As of September 30, 2025, we provided dialysis services to a total of approximately 293,200 patients at 3,247 outpatient dialysis centers, of which 2,662 centers were located in the United States and 585 centers were located in 14 countries outside of the United States.8-K filed 2025-10-29 |
U.S. dialysis revenue per treatment
$415.25 for the period ended Sep 30, 2026
The filings read for this page do not define this measure.
| Period ended | Figure | Filing text |
|---|---|---|
| Sep 30, 2026 | $415.25 | Revenue per treatment · $415.25 · $415.87 · $(0.62) · $416.22 · $405.15 · $11.078-K filed 2026-10-29 |
| Jun 30, 2026 | $415.87 | Revenue per treatment · $415.87 · $417.59 · $(1.72) · $416.71 · $402.38 · $14.338-K filed 2026-08-04 |
| Mar 31, 2026 | $417.59 | Revenue per treatment · $417.59 · $422.60 · $(5.01) · $417.59 · $400.14 · $17.458-K filed 2026-05-05 |
| Dec 31, 2025 | $422.6 | Revenue per treatment · $422.60 · $410.59 · $12.01 · $409.56 · $391.32 · $18.248-K filed 2026-02-02 |
| Sep 30, 2025 | $410.59 | Revenue per treatment · $410.59 · $404.58 · $6.01 · $405.15 · $389.79 · $15.368-K filed 2025-10-29 |
| Jun 30, 2025 | $404.58 | Revenue per treatment · $410.59 · $404.58 · $6.01 · $405.15 · $389.79 · $15.368-K filed 2025-10-29 |
| Mar 31, 2025 | $400.14 | Revenue per treatment · $417.59 · $422.60 · $(5.01) · $417.59 · $400.14 · $17.458-K filed 2026-05-05 |
IKC patients in risk-based integrated care arrangements
≈ 80,800 at Sep 30, 2026
The filings read for this page do not define this measure.
| Period ended | Figure | Filing text |
|---|---|---|
| Sep 30, 2026 | ≈ 80,800As the company words it | As of September 30, 2026, we had approximately 80,800 patients in risk-based integrated care arrangements representing approximately $6.4 billion in annualized medical spend.8-K filed 2026-10-29 |
| Jun 30, 2026 | ≈ 64,900As the company words it | As of June 30, 2026, we had approximately 64,900 patients in risk-based integrated care arrangements representing approximately $5.8 billion in annualized medical spend.8-K filed 2026-08-04 |
| Mar 31, 2026 | ≈ 62,600As the company words it | As of March 31, 2026, we had approximately 62,600 patients in risk-based integrated care arrangements representing approximately $5.4 billion in annualized medical spend.8-K filed 2026-05-05 |
| Dec 31, 2025 | ≈ 66,000As the company words it | Integrated kidney care (IKC): As of December 31, 2025, we had approximately 66,000 patients in risk-based integrated care arrangements representing approximately $5.6 billion in annualized medical spend.8-K filed 2026-02-02 |
| Sep 30, 2025 | ≈ 64,900As the company words it | As of September 30, 2025, we had approximately 64,900 patients in risk-based integrated care arrangements representing approximately $5.5 billion in annualized medical spend.8-K filed 2025-10-29 |
| Mar 31, 2025 | 62,100 | Risk-based(5) · 62,600 · 66,000 · 62,1008-K filed 2026-05-05 |
Reading notes
Figures are shown as first reported. If a later filing prints a different figure for the same period, both appear. A figure marked ≈ or shown in words is how the company itself states it, not an estimate of ours. Companies change definitions over time, so compare periods with the quoted definition in mind. Periods that failed our checks are left out, so gaps are expected.